Advantages of Azithromycin Over Erythromycin in Improving the Gastric Emptying Half-Time in Adult Patients With Gastroparesis

BACKGROUND/AIMS: Current therapy for gastroparesis with prokinetic agents is limited by options and side effects. One macrolide, erythromycin (ERY), is associated with possible sudden cardiac death from QT prolongation due to P450 iso-enzyme inhibition. An alternative, azithromycin (AZI), lacks P450...

Descripción completa

Detalles Bibliográficos
Autores principales: Larson, Jean M, Tavakkoli, Anna, Drane, Walter E, Toskes, Phillip P, Moshiree, Baharak
Formato: Texto
Lenguaje:English
Publicado: Korean Society of Neurogastroenterology and Motility 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978393/
https://www.ncbi.nlm.nih.gov/pubmed/21103422
http://dx.doi.org/10.5056/jnm.2010.16.4.407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978393/
https://www.ncbi.nlm.nih.gov/pubmed/21103422
http://dx.doi.org/10.5056/jnm.2010.16.4.407

Ejemplares similares